XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Millions
Common Stock
Treasury Stock at Cost
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balances at beginning of period at Dec. 31, 2018 $ 0.9 $ (78.1) $ 312.7 $ (6.5) $ (510.8) $ (281.8)
Balances at beginning of period (in shares) at Dec. 31, 2018 82,680,380          
Increase (Decrease) in Stockholders' Deficit            
Changes in accumulated other comprehensive gain (loss)       (9.0)   (9.0)
Stock-based compensation     10.1     10.1
Issuance of restricted stock, net (in shares) 1,609,514          
Purchase of shares   (1.6)       (1.6)
Purchase of shares (in shares) (186,786)          
Net income (loss)         36.4 36.4
Balances at end of period at Dec. 31, 2019 [1] $ 0.9 (79.7) 322.8 (15.5) (474.4) (245.9)
Balances at end of period (in shares) at Dec. 31, 2019 [1] 84,103,108          
Increase (Decrease) in Stockholders' Deficit            
Changes in accumulated other comprehensive gain (loss)       9.0   9.0
Stock-based compensation $ 0.1   11.0     11.1
Issuance of restricted stock, net (in shares) 3,004,954          
Purchase of shares   (1.0)       (1.0)
Purchase of shares (in shares) (260,265)          
Net income (loss)         14.4 14.4
Balances at end of period at Dec. 31, 2020 [1] $ 1.0 (80.7) 333.8 (6.5) (460.0) $ (212.4)
Balances at end of period (in shares) at Dec. 31, 2020 86,847,797 [1]         86,847,797
Increase (Decrease) in Stockholders' Deficit            
Changes in accumulated other comprehensive gain (loss)       $ 6.5   $ 6.5
Stock-based compensation     14.7     14.7
Issuance of restricted stock, net (in shares) 1,038,749          
Purchase of shares   (8.5)       (8.5)
Purchase of shares (in shares) (494,458)          
Net income (loss)         770.5 770.5
Balances at end of period at Dec. 31, 2021 [1] $ 1.0 $ (89.2) $ 348.5   $ 310.5 $ 570.8
Balances at end of period (in shares) at Dec. 31, 2021 87,392,088 [1]         87,392,088
[1] Included in outstanding shares as of December 31, 2021, 2020 and 2019 are 4,325,124, 4,990,971 and 3,140,168, respectively, of non-vested shares of restricted stock awards granted to employees and directors.